Huntsman has managed to rebuff a move by activist investor Starboard Value to appoint four members to the chemical company’s board. According to preliminary results from...
Gearing up for a potential proxy fight at its Mar. 25 annual meeting, Huntsman has written to its shareholders urging them to vote for the company’s nominated directors...
Activist investor Starboard Value has nominated four directors to Huntsman’s board, launching a potential proxy fight. Its candidates are Jeffrey Smith, Starboard’s...
02.04.2019
- Activist investor Starboard Value has backed away from plans to torpedo the proposed $74 billion merger of Bristol-Myers Squibb with Celgene after independent proxy advisory firms...
22.02.2019
- Activist shareholder Starboard Value has acquired an interest of 1 million share of Bristol-Myers Squibb (BMS) and has held meetings with management, the US drugmaker said. BMS...
